FDA approved Drugs Collection
A unique library of most diverse drugs
1 123 compounds
Drug repurposing is a promising field in drug discovery that identifies new therapeutic opportunities for existing drugs (e.g. Metformin and Raloxifene). High-content screens, new biomarkers, and noninvasive imaging techniques have created new capabilities for pursuing novel indications for approved compounds. Hits from our FDA Approved Drug Collection will provide a significant head start in any drug optimization program.
- Carefully collected and distilled collection of 1 123 FDA approved drugs
- Supported with full bioactivity annotation, pathway indications and all related chemical structure information (structure, CAS, smiles, molecular parameters)
- NMR and HPLC validated to ensure the highest purity
- Supplied in 96, 384 or 1536-well plates, ready for immediate shipping
- Minimal preparation – just peel, dilute & transfer to assay plate
Download SD files
Library code: FAD-1123
Version: 9 November 2023
1 123 compounds
sublibrary of Bioreference Library
Therapeutic areas
Target distribution
Typical Formats
Catalog No.
FAD-1123-0-Y-2
Compounds
1 123
Amount
≤ 150 nL of 2 mM DMSO solution
Plates and formats
384-well polypropylene plates, first and last two columns empty 320 compounds per plate
Request a quote
This email address is being protected from spambots. You need JavaScript enabled to view it.
Catalog No.
FAD-1123-10-Y-10
Compounds
1 123
Amount
10 µL of 10 mM DMSO solution
Plates and formats
384-well echo-compatible plates: first and last columns empty LP200
Request a quote
This email address is being protected from spambots. You need JavaScript enabled to view it.
Catalog No.
FAD-1123-50-Y/X-10
Compounds
1 123
Amount
50 µL of 10 mM DMSO solution
Plates and formats
384-well or 96-well plates: first and last columns empty
Request a quote
This email address is being protected from spambots. You need JavaScript enabled to view it.
Catalog No.
FAD-1123
Compounds
1 123
Amount
Custom
Plates and formats
Any custom format
Price
This email address is being protected from spambots. You need JavaScript enabled to view it.
